Fosfomycin trometamol (monuralr3g) in tratamentul empiric infectiei urinare joase la femei
Închide
Conţinutul numărului revistei
Articolul precedent
Articolul urmator
306 6
Ultima descărcare din IBN:
2024-01-21 10:19
SM ISO690:2012
OPREA, Andrei, PITERSCHI, Alexandru, PLEȘCO, Sergiu, TRICOLICI, Ghenadie. Fosfomycin trometamol (monuralr3g) in tratamentul empiric infectiei urinare joase la femei. In: Arta Medica , 2011, nr. 2S(45), pp. 123-125. ISSN 1810-1852.
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
Arta Medica
Numărul 2S(45) / 2011 / ISSN 1810-1852 /ISSNe 1810-1879

Fosfomycin trometamol (monuralr3g) in tratamentul empiric infectiei urinare joase la femei

Fosfomycin trometamol (monuralr3g) in empiric treatment of the low urinary infection in female


Pag. 123-125

Oprea Andrei1, Piterschi Alexandru1, Pleșco Sergiu2, Tricolici Ghenadie3
 
1 Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“,
2 IMSP Spitalul Raional, Cahul,
3 IMSP Spitalul Raional Drochia
 
 
Disponibil în IBN: 28 martie 2022


Rezumat

This study was conducted to assess the clinical and microbiological efficacies of a single 3-g dose of fosfomycin trometamol for the treatment of cystitis in women. 77,6% of pathogens were Escherichia coli. A clinical evaluation at the 5-7 day follow-up showed that 100% of the women were free of symptoms, the microbiological evaluation at the 5-7 day of follow-up showed a 96% eradication rate. A microbiological evaluation at 1 month demonstrated prolonged eradication in 92% women. Only in one case were reported adverse reactions. Fosfomycin trometamol in a single 3-g dose is effective in the treatment of cystitis.